Technology
Health
Pharmaceutical

Assertio Therapeutics

$3.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.15 (4.65%) As of 3:41 PM EDT today
+$0.15 (4.65%) Today

Why Robinhood?

You can buy or sell ASRT and other stocks, options, ETFs, and crypto commission-free!

About ASRT

Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. Read More The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL.

Employees
116
Headquarters
Lake Forest, Illinois
Founded
1995
Market Cap
200.71M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
844.09K
High Today
$3.29
Low Today
$3.11
Open Price
$3.11
Volume
402.99K
52 Week High
$9.48
52 Week Low
$2.88

Collections

Technology
Health
Pharmaceutical
Therapy
US
North America

ASRT Earnings

$0.11
$0.21
$0.32
$0.42
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.